This retrospective real-life study aims to determine if Finnish patients receiving biological therapy for severe asthma benefit from the treatment due to reduction in exacerbations, OCS dose and courses of OCS and antibiotics in a real-life setting with a broader population than in a randomised controlled trial, and to compare anti-IL5/IL5R therapy results with anti-IgE therapy results in a real-life setting. It also aims to describe the impact of biological therapy on upper respiratory tract findings and need for treatment in asthma patients receiving biologicals.
Featured article: A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Articles
-
-
The outcome of COVID-19 among the geriatric age group in African countries: protocol for a systematic review and meta-analysis
-
Disease control in patients with asthma and respiratory symptoms (wheezing, cough) during sleep
-
The burden, admission, and outcomes of COVID-19 among asthmatic patients in Africa: protocol for a systematic review and meta-analysis
-
The healthcare seeking behaviour of adult patients with asthma at Chitungwiza Central Hospital, Zimbabwe
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Aims and scope
Asthma Research and Practice publishes cutting edge basic, clinical and translational research in addition to hot topic reviews and debate articles relevant to asthma and related disorders (such as rhinitis, COPD overlapping syndrome, sinusitis). The journal has a specialized section which focusses on pediatric asthma research.
Asthma Research and Practice aims to serve as an international platform for the dissemination of research of interest to pulmonologists, allergologists, primary care physicians and family doctors, ENTs and other health care providers interested in asthma, its mechanisms and comorbidities.
Follow
Annual Journal Metrics
-
Speed
80 days to first decision for reviewed manuscripts only
78 days to first decision for all manuscripts
133 days from submission to acceptance
16 days from acceptance to publicationUsage
74,526 Downloads
59 Altmetric mentions
